NCT06376058View on ClinicalTrials.gov

Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 10, 2024

Primary Completion Date

January 10, 2026

Study Completion Date

January 10, 2026

Conditions
Cesarean SectionLocal Anesthetic
Interventions
DRUG

Chloroprocaine 1% Injectable Solution

• in parturients allocated to the chloroprocaine group, a fixed dose of chloroprocaine 1% will be administered intrathecally

DRUG

Ropivacaine 0.75% Injectable Solution

• in parturients allocated to the ropivacaine group, a fixed dose of ropivacaine 0.75% will be administered intrathecally

Trial Locations (1)

11528

RECRUITING

Aretaieion University Hospital, Athens

All Listed Sponsors
lead

Aretaieion University Hospital

OTHER